FAS and FAS-L expression by tumor cells and lymphocytes in breast carcinomas and their lymph node metastases
- 1 February 2005
- journal article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 200 (11-12) , 743-751
- https://doi.org/10.1016/j.prp.2004.09.006
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Fas and Fas ligand expression is elevated in prostatic intraepithelial neoplasia and prostatic adenocarcinomaCancer, 2002
- Fas/Fas ligand system and apoptosis induction in testicular carcinomaCancer, 2002
- Autocrine and Paracrine Growth Mechanisms in Cancer Progression and MetastasisPublished by Elsevier ,2002
- Molecular Mechanisms of Cancer InvasionPublished by Elsevier ,2002
- Lymph node metastasesCancer, 2000
- Fas ligand is not only expressed in immune privileged human organs but is also coexpressed with Fas in various epithelial tissues.Molecular Pathology, 1997
- Apoptosis by Death FactorCell, 1997
- Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune EscapeScience, 1996
- p53 Mutations in Human CancersScience, 1991
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990